Pharma, Biotech & Chem IP Strategy

Introducing Think IP Strategy – Wednesday, March 17, 2010

Be polite, damn it – Tuesday, March 16, 2010

What if patents lasted 70 years? – Thursday, March 4, 2010

Invention capital Intellectual Ventures and You – Tuesday, March 2, 2010

Pharmaceutical patent settlements - and what about patients? – Thursday, February 25, 2010

Scratch that assumption - industrial applicability really does have teeth – Thursday, February 18, 2010

Gong Xi Fa Cai (Happy Chinese New Year) – Sunday, February 14, 2010

2010 IP Hall of Fame inductees announced – Tuesday, February 9, 2010

THE China IP litigation resource? and its free – Thursday, February 4, 2010

Licensing Executives Society (USA & Canada) Celebrates 45 Years – Tuesday, February 2, 2010

A little bit of background on Duncan – Tuesday, January 26, 2010

Changing the game in pharma patent strategy – Tuesday, January 19, 2010

IPThinkTank - now an iPhone App – Thursday, January 14, 2010

New Article - patent harmony in Europe – Tuesday, January 12, 2010

Once in a lifetime chance to guest blog at Patent Baristas – Thursday, January 7, 2010

Behind the scenes at IP Think Tank podcasts – Wednesday, January 6, 2010

The 8 intellectual property enthusiasts to watch – Tuesday, January 5, 2010

Happy New Year! – Friday, January 1, 2010

Happy Christmas from all of us – Thursday, December 24, 2009

Forbidden City, global firm and thank you – Monday, November 23, 2009

Release the tweets - IPBC09 and beyond – Thursday, August 6, 2009

23 client engagements 25 countries July 2009 insights from Duncan Bucknell Company – Saturday, August 1, 2009

BioPharma royalties European customs Utah and software - Thoughts on les Nouvelles Jun 09 – Tuesday, July 28, 2009

Intellectual Ventures Microsoft GSK and Elephants - Thoughts on IAM Magazine Issue 36 Jul Aug 09 – Thursday, July 9, 2009

20 client engagements 35 countries June 2009 insights from Duncan Bucknell Company – Tuesday, June 30, 2009

Vote 1 IP Think Tank? – Thursday, May 28, 2009

The cheapest way to invalidate a patent – Tuesday, May 19, 2009

Pharmaceutical manufacture for export - resources and update – Friday, May 1, 2009

Blockbusters and other strategies – Monday, April 13, 2009

Pharmaceutical manufacture for export - what do you think? – Wednesday, April 8, 2009

Access to medicines, patent fundamentals meet up with Vandana – Monday, April 6, 2009

Should authorised generics be abolished? – Thursday, February 12, 2009

Heartfelt sympathies to victims of Australia's worst natural disaster Bushfires still raging – Sunday, February 8, 2009

Please tell us what you want in an IP podcast. – Wednesday, February 4, 2009

Drug controllers to analyse patents while patent controllers analyse efficacy – Thursday, January 15, 2009

Seasons greetings from Duncan Bucknell Company – Tuesday, December 23, 2008

Less tactics and more strategy if you please – Monday, December 15, 2008

The Impact of Pre-grant Opposition on Patents – New Book by Advocate Feroz Ali – Tuesday, December 9, 2008

Announcing Global IP Events in IP Think Tank – Friday, November 28, 2008

EC Pharma Sector enquiry - from dawn raids to no individual wrongdoing – Friday, November 28, 2008

IP Think Tank Global Week in Review Pharma & Biotech Edition – 14 November 2008 – Thursday, November 13, 2008

Blawg Review #185 – Monday, November 10, 2008

What can your competitors expect from you? – Wednesday, October 22, 2008

Pharmaceutical IP management & strategy - your thoughts? – Thursday, October 9, 2008

Faster, Zyprexa and the Oberlandesgericht Dusseldorf – Wednesday, September 17, 2008

Speaking Engagements (India) GenericsWeb Patent Academies 6 and 8 Oct 08 – Friday, September 5, 2008

Reasonable enquiries before filing an IP law suit - not in US pharmaceuticals? – Tuesday, August 5, 2008

Stop press - Pfizer and Ranbaxy Settle Lipitor dispute (mostly) Worldwide – Wednesday, June 18, 2008

Is Lipitor driving Pfizer and Sankyo's Ranbaxy bidding? – Monday, June 16, 2008

New Article - pharmaceutical polymorphs & patent strategy – Wednesday, May 21, 2008

Blogger Appreciation Day – Thursday, April 17, 2008

New company, new team, new website features – Monday, April 7, 2008

Speaking engagements - Generic Medicines - 20 May 2008 – Monday, March 17, 2008

Speaking engagements - IP Business Congress 2008 - Amsterdam, 25 June 2008 – Tuesday, March 11, 2008

29 Billion reasons to litigate? – Wednesday, February 20, 2008

Speaking engagements - GenericsWeb Patent Academy - 6 Feb 08 – Thursday, January 24, 2008

Glivec, Gleevec (Imatinib) Novartis' crystalline form strategy – Tuesday, January 15, 2008

Happy New Year – Tuesday, January 1, 2008

IP Think Tank - short break – Monday, December 24, 2007

Shaping the Terrain and IP Strategy – Wednesday, December 19, 2007

Generic company's Detrol Polymorph Patent Highlights Ongoing Quality Issues in USPTO – Monday, December 17, 2007

Patent Uncertainty and Patent Academy – Tuesday, November 13, 2007

IP Think Tank Top Fives – Thursday, November 8, 2007

Delaying grant of a competitor's patent - strategic or nonsense? – Wednesday, November 7, 2007

On a Different Topic – Thank You! – Tuesday, November 6, 2007

Monsanto's costly patent strategy mistake – Monday, October 29, 2007

Global IP Scorecards - popular 'table view' returns – Wednesday, October 24, 2007

Pharmaceutical Lifecycle Management & IP acquisitions – Tuesday, October 23, 2007

Generic exclusivity extended? - Teva sues 16th generic over Carvedilol – Thursday, October 18, 2007

Getting better all the time - with your help – Monday, October 15, 2007

Patent interim injunctions, clearing the way and patent strategy – Thursday, October 4, 2007

IP bounty hunters? - using social networks to invalidate IP rights – Monday, September 24, 2007

Kenya pauses, then swims with the (compulsory license) tide – Wednesday, September 19, 2007

New Article - Pharmaceutical & Biotech Lifecycle Management (II) - non-innovator patents – Sunday, September 16, 2007

Spicy IP Strategy – Wednesday, September 12, 2007

Thanks so much - July & August '07 coversations on IP ThinkTank – Monday, September 3, 2007

Stop them at the border! USITC proceedings on the rise in light of eBay – Friday, August 31, 2007

Will the new USPTO Rules hurt Pharma ? – Wednesday, August 29, 2007

Is obfuscation the best route to the UK Court of Appeal? – Monday, August 27, 2007

Making life easier for you – Friday, August 24, 2007

Within 24 hrs USPTO sued over new Continuation Rules – Thursday, August 23, 2007

New Scorecard - Compulsory Licenses around the globe – Wednesday, August 22, 2007

Watering down willful infringement in the US - In Re Seagate – Tuesday, August 21, 2007

Lifecycle Management at risk? Will Asian countries follow India's 3(d) lead? – Monday, August 20, 2007

Thumb screws from the USPTO - strategic implications – Friday, August 17, 2007

US / China TRIPS case goes to WTO panel - what about India? – Wednesday, August 15, 2007

Article awards - popularity on Mondaq – Tuesday, August 14, 2007

India, TRIPS, pharmaceuticals and patents – Monday, August 13, 2007

Nucleonics seeks en banc rehearing of Benitec decision – Tuesday, August 7, 2007

New Article - Novartis' glivec battle with India - patentability of pharmaceutical extension patents – Monday, August 6, 2007

New Article - Australia even more patent-friendly after High Court decision – Sunday, August 5, 2007

Patent litigation in India - uncommon and in need of reform? – Friday, August 3, 2007

PubPat - the public interest patent challenger – Wednesday, August 1, 2007

Where (not) to litigate IP – Monday, July 30, 2007

Lipitor (Zarator or Cardyl) in Spain - mixed success but no launch for Ranbaxy – Wednesday, July 25, 2007

What to do in the US if you don't have standing to sue for revocation - more on Benitec v Nucleonics – Tuesday, July 24, 2007

Do we have enough controversy? - Declaratory Judgments in the US – Monday, July 23, 2007

Are patents worth it? The NY Times article furore. – Friday, July 20, 2007

New Article - Pharmaceutical & Biotech Lifecycle Management (I) – Tuesday, July 17, 2007

Lipitor in Ireland, no luck here, either – Thursday, July 12, 2007

Generic exclusivity by alternate means - Teva sues 7 generics over Carvedilol – Monday, July 9, 2007

Lifecycle Management - pharma specific? – Thursday, July 5, 2007

Glivec - what's at stake for Novartis and for India? – Monday, June 25, 2007